CICERO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 8.436
EU - Europa 2.919
AS - Asia 1.145
AF - Africa 29
OC - Oceania 21
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.574
Nazione #
US - Stati Uniti d'America 8.419
IT - Italia 894
CN - Cina 643
FI - Finlandia 597
DE - Germania 340
SG - Singapore 289
UA - Ucraina 248
GB - Regno Unito 211
IE - Irlanda 204
SE - Svezia 104
RU - Federazione Russa 91
IN - India 55
RO - Romania 53
BE - Belgio 52
FR - Francia 46
TR - Turchia 36
KR - Corea 27
IR - Iran 19
NL - Olanda 18
AU - Australia 17
CI - Costa d'Avorio 17
CA - Canada 13
ES - Italia 13
HK - Hong Kong 13
PL - Polonia 12
JP - Giappone 9
MY - Malesia 9
AT - Austria 8
IL - Israele 8
AR - Argentina 7
EU - Europa 6
TW - Taiwan 6
CH - Svizzera 5
ID - Indonesia 5
NO - Norvegia 5
KW - Kuwait 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SD - Sudan 4
UZ - Uzbekistan 4
BR - Brasile 3
CL - Cile 3
CO - Colombia 3
KZ - Kazakistan 3
LB - Libano 3
MX - Messico 3
PH - Filippine 3
VN - Vietnam 3
ZA - Sudafrica 3
BG - Bulgaria 2
CM - Camerun 2
DK - Danimarca 2
LT - Lituania 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
SI - Slovenia 1
TH - Thailandia 1
VE - Venezuela 1
Totale 12.574
Città #
Fairfield 1.374
Ashburn 801
Woodbridge 746
Chandler 696
Wilmington 552
Seattle 550
Houston 548
Ann Arbor 525
Cambridge 479
Palermo 242
Singapore 232
Dublin 201
Medford 167
Jacksonville 128
Altamura 116
Des Moines 108
Nanjing 108
Princeton 103
Lawrence 90
Santa Clara 85
San Diego 78
Dearborn 70
New York 69
Hefei 61
Boardman 56
Beijing 55
Brussels 50
Changsha 50
Shenyang 49
Tulsa 49
Milan 43
Ludwigshafen am Rhein 39
Nanchang 36
Hebei 33
Bremen 31
Jinan 31
London 30
Kumar 29
Jiaxing 28
Zhengzhou 27
Izmir 25
Tianjin 24
Redwood City 23
Phoenix 22
Los Angeles 21
Falls Church 20
Ningbo 20
Berlin 19
Helsinki 19
Saint Petersburg 19
Guangzhou 18
Seongnam 18
Abidjan 17
Chicago 16
Rome 16
Munich 15
Verona 15
Auburn Hills 14
Hangzhou 13
Pune 13
San Paolo di Civitate 13
Venice 13
Tehran 12
Kitzingen 11
Taizhou 11
Lanzhou 10
Redmond 9
Amsterdam 8
Toronto 8
Turin 8
Edinburgh 7
Frankfurt am Main 7
Indiana 7
Orange 7
Taiyuan 7
Washington 7
Aversa 6
La Jolla 6
Moscow 6
Tokyo 6
Forest City 5
Haikou 5
Islington 5
Kilburn 5
Kunming 5
Munro 5
Napoli 5
Norwalk 5
Piscataway 5
Saint Louis 5
San Mateo 5
Selby 5
Shanghai 5
Stockholm 5
Sydney 5
Atlanta 4
Bergamo 4
Bologna 4
Central District 4
Dallas 4
Totale 9.396
Nome #
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 212
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 204
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 201
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 200
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 195
Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature 195
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 193
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 191
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 190
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 189
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 188
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 179
A headlight on liquid biopsies: a challenging tool for breast cancer management 175
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 174
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 172
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 172
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 172
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 169
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 168
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 167
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 166
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 162
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 161
Targeted Therapies in Hepatocellular Carcinoma 161
Monoclonal antibodies in gastrointestinal cancers 161
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 160
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 160
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 160
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 159
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 158
Primary Non-Hodgkin’s lymphoma of the parotid gland 155
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 155
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 153
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. 151
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 148
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 148
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 148
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 146
HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY 146
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 146
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life 146
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 146
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 144
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 142
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 141
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 141
The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician 139
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 138
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 135
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 132
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer 132
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 130
Well-being among Italian medical oncologists: An exploratory study 130
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 128
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 127
The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer 124
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 121
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer 120
Circulating exosomal Hsp60 as a new marker of colon cancer. 119
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 118
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 118
Geldanamycin and its derivatives as Hsp90 inhibitors 117
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience 117
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 113
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 113
The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study 113
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 112
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 112
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 110
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 110
Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo 109
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica 109
Bortezomib: a new pro-apoptotic agent in cancer treatment. 107
Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience 107
Ramucirumab and its use in gastric cancer treatment 106
Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience 102
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 101
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis 96
Emergenze metaboliche 94
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 92
Unusual case of dorsal vertebral metastases from a male breast cancer 91
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 88
Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. 84
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 84
A rare case of extra-intramedullary dorsal tanycitic ependymoma, radically removed with intraoperative neurophysiological monitoring 80
Cardiotossicità e Cardioprotezione. 79
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vc9Vd2 T Cell-Mediated Cytotoxicity 75
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 72
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients 66
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study 66
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams 64
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 63
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 62
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 60
Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study 58
Terapia medica e supporto psicologico in un gruppo di pazienti affette da carcinoma mammario 57
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 53
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life 52
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study 44
Gene expression profiling of cumulus oophorus cells reveals altered pathways in patients with endometriosis 42
Totale 12.961
Categoria #
all - tutte 47.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.806 0 0 0 477 396 424 342 276 327 194 278 92
2020/20211.606 108 108 133 143 101 73 101 123 193 203 150 170
2021/20221.542 70 310 65 98 78 73 91 108 158 130 129 232
2022/20231.932 198 384 38 237 217 265 84 157 194 11 99 48
2023/2024898 35 107 60 68 58 165 80 111 7 28 42 137
2024/2025542 49 176 233 84 0 0 0 0 0 0 0 0
Totale 13.139